Bellerophon Therapeutics is Biotechnology in United States that focus on Bellerophon Therapeutics Inc business. Founded in 2013. They cover business area such as Bellerophon Therapeutics Inc, innovative product, novel drug, device, cardiopulmonary disease, its inopulse platform, an extension, hospital, continuous-flow inhale nitric oxide, different kind, pulmonary hypertension.
2013
( 13 years old in 2026 )
Bellerophon Therapeutics Inc
-
184 Liberty Corner Road
Suite 302
Warren, NJ 07059
United States
Private
Bellerophon Therapeutics Incinnovative productnovel drugdevicecardiopulmonary diseaseits inopulse platforman extensionhospitalcontinuous-flow inhale nitric oxidedifferent kindpulmonary hypertension
* We use standard office opening hours in near Bellerophon Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bellerophon Therapeutics is Biotechnology business from United States that founded in 2013 (13 years old in 2026), Bellerophon Therapeutics business is focusing on Bellerophon Therapeutics Inc.
Bellerophon Therapeutics headquarter office and corporate office address is located in 184 Liberty Corner Road Suite 302 Warren, NJ 07059 United States.
Bellerophon Therapeutics was founded in United States.
In 2026, Bellerophon Therapeutics is currently focus on Bellerophon Therapeutics Inc sector.
Above is snippet of Google Trends for "Bellerophon Therapeutics Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bellerophon Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
